Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vermeire

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Alimentary Pharmacology & Therapeutics|January 19, 2007
Review article: Altering the natural history of Crohn's disease--evidence for and against current therapiesS Vermeire, G van Assche, P Rutgeerts
Alimentary Pharmacology & Therapeutics|March 13, 2012
Commentary: BMI and the need for adalimumab dose escalation in Crohn's diseaseG Van Assche, F Baert, S Vermeire
Inflammatory Bowel Diseases|March 7, 2009
Likelihood ratio for Crohn's disease as a function of anti-Saccharomyces cerevisiae antibody concentrationN Vermeulen, S Vermeire, P Rutgeerts, et al.
Acta Gastro-Enterologica Belgica|December 14, 2007
Azathioprine induced colitis: a case report and review of the literatureP Bossuyt, P Vergauwe, N Inderadjaja, et al.
Inflammatory Bowel Diseases|January 10, 2001
Familial and sporadic inflammatory bowel disease: different entities?M Peeters, A Cortot, S Vermeire, et al.
Acta Gastro-Enterologica Belgica|March 26, 2009
Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?C Breynaert, S Vermeire, P Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2014
Review article: anti-adhesion therapies for inflammatory bowel diseaseT Lobatón, S Vermeire, G Van Assche, et al.
Acta Clinica Belgica|May 25, 2010
Severity (and treatment) of chronic lithium poisoning: clinical signs or lab results as a criterion?S Vermeire, P Vanbrabant, P Van Boxstael, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 11, 2008
Infliximab for pediatric Crohn's diseaseI Hoffman, S Vermeire, G Van Assche, et al.
Acta Gastro-Enterologica Belgica|August 30, 2008
A unique combination of celiac disease, mesenteric lymph node cavitation, splenic atrophy and necrotizing hepatitisT Cornelis, M Hiele, S Vermeire, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|January 19, 2007
Review article: Altering the natural history of Crohn's disease--evidence for and against current therapiesS Vermeire, G van Assche, P Rutgeerts
Alimentary Pharmacology & Therapeutics|March 13, 2012
Commentary: BMI and the need for adalimumab dose escalation in Crohn's diseaseG Van Assche, F Baert, S Vermeire
Inflammatory Bowel Diseases|March 7, 2009
Likelihood ratio for Crohn's disease as a function of anti-Saccharomyces cerevisiae antibody concentrationN Vermeulen, S Vermeire, P Rutgeerts, et al.
Acta Gastro-Enterologica Belgica|December 14, 2007
Azathioprine induced colitis: a case report and review of the literatureP Bossuyt, P Vergauwe, N Inderadjaja, et al.
Inflammatory Bowel Diseases|January 10, 2001
Familial and sporadic inflammatory bowel disease: different entities?M Peeters, A Cortot, S Vermeire, et al.
Acta Gastro-Enterologica Belgica|March 26, 2009
Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?C Breynaert, S Vermeire, P Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2014
Review article: anti-adhesion therapies for inflammatory bowel diseaseT Lobatón, S Vermeire, G Van Assche, et al.
Acta Clinica Belgica|May 25, 2010
Severity (and treatment) of chronic lithium poisoning: clinical signs or lab results as a criterion?S Vermeire, P Vanbrabant, P Van Boxstael, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 11, 2008
Infliximab for pediatric Crohn's diseaseI Hoffman, S Vermeire, G Van Assche, et al.
Acta Gastro-Enterologica Belgica|August 30, 2008
A unique combination of celiac disease, mesenteric lymph node cavitation, splenic atrophy and necrotizing hepatitisT Cornelis, M Hiele, S Vermeire, et al.
Pageof 14